Scarica l'app Stockscreener
6.98
3.46%
-0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AURA Giù?
Forum
Previsione
Precedente Chiudi:
$7.23
Aprire:
$7.12
Volume 24 ore:
12,006
Relative Volume:
0.06
Capitalizzazione di mercato:
$350.88M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-3.6354
EPS:
-1.92
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
+6.56%
1M Prestazione:
+3.41%
6M Prestazione:
-12.20%
1 anno Prestazione:
-10.28%
Intervallo 1D:
$6.90
$7.18
Intervallo di 1 settimana:
$6.3424
$7.40
Portata 52W:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Nome
Aura Biosciences Inc
Settore
Industria
Telefono
(617)500-8864
Indirizzo
80 GUEST STREET, BOSTON
Confronta AURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.98 | 430.31M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.06 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.91 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.22 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
647.24 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.00 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Ripresa | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-07-19 | Iniziato | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Borsa (AURA) Ultime notizie
What institutional flow reveals about Aura Biosciences Inc.2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Market reaction to Aura Biosciences Inc.’s recent newsJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
Aura Biosciences Advances Clinical Trials and Strengthens Finances - TipRanks
Certain Warrants of Aura Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 14-AUG-2025. - MarketScreener
Aura Biosciences Inc: Promising Clinical Developments and Strong Financial Position Support Buy Rating - TipRanks
Aura Biosciences Inc’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating - TipRanks
Positive Outlook on Aura Biosciences: Strategic Developments and Promising Trials Drive Buy Rating - TipRanks
Aura Biosciences: A Strategic Play in High-Unmet-Need Ocular and Urologic Oncology - AInvest
Order flow analysis tools used on Aura Biosciences Inc.July 2025 Movers & Safe Capital Growth Tips - Newser
What MACD and RSI say about Aura Biosciences Inc.2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Aura Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Is Aura Biosciences Inc. forming a reversal patternEarnings Recap Report & Fast Gaining Stock Reports - Newser
Aura Biosciences Q2 revenue down 36%, cash to fund ops into H1 2027. - AInvest
Aura Biosciences Reports Q2 Results and $75M Financing - TipRanks
Aura Biosciences : Corporate Presentation August 2025 - MarketScreener
Aura Biosciences Posts Q2 Cash Surge - The Motley Fool
Aura Biosciences Posts Q2 Cash Surge - Nasdaq
Aura's Vision-Preserving Cancer Therapy Gains Momentum with $75M Boost, Trial Progress - Stock Titan
Aura Biosciences Inc. Trading Near Value Zone — Recovery AheadRisk Controlled Picks With Real Returns Outlined - 선데이타임즈
Regression analysis insights on Aura Biosciences Inc. performancePortfolio Building Plan and Summary Guide - Newser
What makes Aura Biosciences Inc. stock price move sharplyPredictive Model for Intraday Swing Forecast - Newser
Combining price and volume data for Aura Biosciences Inc.Portfolio Allocation Strategy for Stability - Newser
Aura Biosciences Inc.’s volatility index tracking explainedMarket Liquidity and Price Flow Analysis - Newser
Key resistance and support levels for Aura Biosciences Inc.Weekly High Conviction Trade Setup Analysis - Newser
Traders Watching For Reversal Pattern in Aura Biosciences Inc.Real-Time Market Sentiment Tracking Gains Momentum - beatles.ru
Can Aura Biosciences Inc. rally from current levelsBuy Signal System Based on Price Action - Newser
Analyzing drawdowns of Aura Biosciences Inc. with statistical toolsFree Access to Real-Time Trade Insights - Newser
Understanding Aura Biosciences Inc.’s price movementSmart Chart Forecasting with AI Algorithms - Newser
Aura Biosciences (AURA) Expected to Announce Quarterly Earnings on Thursday - Defense World
Aura Biosciences Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Why Aura Biosciences Inc. stock attracts strong analyst attentionSmart Trend Analysis With Buy Point Cues - Newser
Aura Biosciences shares fall 1.78% intraday as Wall Street recovers from Friday's selloff. - AInvest
Aura Biosciences Inc Azioni (AURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aura Biosciences Inc Azioni (AURA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Johnson David Michael | Director |
May 16 '25 |
Buy |
4.90 |
20,000 |
98,000 |
166,167 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Buy |
4.90 |
50,000 |
245,000 |
58,452 |
| Gibney Anthony S | See Remarks |
May 16 '25 |
Sale |
5.15 |
1,519 |
7,823 |
56,933 |
0.36%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):